Treatment of Pituitary Adenomas

Publisher Website
Google Scholar
Abstract
Patients with pituitary adenomas present with diverse clinical syndromes related to the secretory activity of the tumor and the amount of residual normal pituitary tissue. Thyrotropin-producing pituitary adenomas are rare, but patients with this problem may be difficult to treat. The report by Comi and coworkers1 in this issue of the Journal contains evidence that a somatostatin analogue provides effective medical therapy for this uncommon hormone-producing pituitary adenoma. Several investigators, including those at the National Institutes of Health,2 3 4 have successfully used the long-acting somatostatin analogue SMS 201–995 in the treatment of patients with acromegaly. Comi and colleagues document the value . . .